BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 16374637)

  • 1. Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
    El-Husseini A; El-Basuony F; Mahmoud I; Donia A; Sheashaa H; Sabry A; Hassan N; Sayed-Ahmad N; Sobh M
    Eur J Clin Pharmacol; 2006 Jan; 62(1):3-8. PubMed ID: 16374637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-administration of cyclosporine and ketoconazole in idiopathic childhood nephrosis.
    el-Husseini A; el-Basuony F; Mahmoud I; Donia A; Hassan N; Sayed-Ahmad N; Sobh M
    Pediatr Nephrol; 2004 Sep; 19(9):976-81. PubMed ID: 15241676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant administration of cyclosporine and ketoconazole in idiopathic nephrotic syndrome.
    El-Husseini A; El-Basuony F; Donia A; Mahmoud I; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2004 Sep; 19(9):2266-71. PubMed ID: 15238631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of concomitant administration of cyclosporine and ketoconazole in children with focal segmental glomerulosclerosis.
    El-Husseini A; El-Basuony F; Mahmoud I; Donia A; Hassan N; Sayed-Ahmed N; Sobh M
    Am J Nephrol; 2004; 24(3):301-6. PubMed ID: 15133323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-administration of cyclosporine and ketoconazole in children with minimal change nephrotic syndrome.
    El-Husseini A; El-Basuony F; Donia A; Mahmoud I; Hassan N; Sayed-Ahmad N; Sheashaa H; Sabry A; Sobh M
    Nephron Clin Pract; 2005; 100(2):c27-32. PubMed ID: 15775719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study.
    Sheashaa H; Mahmoud I; El-Basuony F; El-Husseini A; Hassan N; El-Baz M; Ahmed NS; Sobh M
    Int Urol Nephrol; 2007; 39(3):923-8. PubMed ID: 17447154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Sabry A; El-Husseini A; El-Dahshan K; Sobh M
    Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
    Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
    Fujinaga S; Ohtomo Y; Someya T; Shimizu T; Yamashiro Y; Kaneko K
    Clin Nephrol; 2008 Feb; 69(2):84-9. PubMed ID: 18218301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
    Hamed RM
    J Nephrol; 1997; 10(5):266-70. PubMed ID: 9364319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
    Nakahata T; Tanaka H; Tsugawa K; Kudo M; Suzuki K; Ito E; Waga S
    Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S; Zamora I; Berbel O; Sanahuja MJ; Fuentes J; Simon J
    Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
    Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
    Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS; Sorof JM; Brewer ED; Kale AS
    Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.